(The Hill) – The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 ...

Thirty-five cases of adverse reactions or serious side effects were reported in Korea within the first month of the release of Mounjaro (tirzepatide), a weight loss drug developed by Eli Lilly.

FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health ...

Diagnosing obesity should move beyond measuring body mass index (BMI), the experts recommended – Copyright Firefly Aerospace/AFP/File – The rise of blockbuster ...